<p>Enzo Biochem Inc. held a special meeting of shareholders on August 19, 2025. The shareholders approved the adoption of the Agreement and Plan of Merger, allowing the merger of Bethpage Merger Sub, Inc. with and into the company. An adjournment proposal was also solicited but was not necessary or presented, as the merger proposal was approved. The merger is expected to close on or about August 20, 2025, subject to the satisfaction or waiver of other closing conditions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enzo Biochem Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-078465), on August 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>Enzo Biochem Inc. held a special shareholder meeting on August 19, 2025, where shareholders approved the merger with Bethpage Merger Sub, Inc. The merger is expected to close around August 20, 2025, pending other closing conditions. An adjournment proposal was not necessary as the merger proposal was approved.</p>

Enzo Biochem Inc. Held Special Shareholder Meeting